Glaukos Corp (GKOS)
144.11
+3.28
(+2.33%)
USD |
NYSE |
Nov 22, 16:00
144.11
0.00 (0.00%)
After-Hours: 17:30
Glaukos Revenue (Annual): 314.71M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 314.71M |
| December 31, 2022 | 282.86M |
| December 31, 2021 | 294.01M |
| December 31, 2020 | 224.96M |
| December 31, 2019 | 236.98M |
| December 31, 2018 | 181.28M |
| Date | Value |
|---|---|
| December 31, 2017 | 159.25M |
| December 31, 2016 | 114.40M |
| December 31, 2015 | 71.70M |
| December 31, 2014 | 45.59M |
| December 31, 2013 | 20.95M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
224.96M
Minimum
2020
314.71M
Maximum
2023
270.71M
Average
282.86M
Median
2022
Revenue (Annual) Benchmarks
| Boston Scientific Corp | 14.24B |
| Baxter International Inc | 14.81B |
| Masimo Corp | 2.048B |
| Teleflex Inc | 2.974B |
| Perspective Therapeutics Inc | -- |